140 related articles for article (PubMed ID: 24703714)
1. The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate.
She Z; Zhang T; Wang X; Li X; Song Y; Cheng X; Huang Z; Deng Y
Biomaterials; 2014 Jun; 35(19):5216-25. PubMed ID: 24703714
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatment.
Luo X; Hu L; Zheng H; Liu M; Liu X; Li C; Qiu Q; Zhao Z; Cheng X; Lai C; Su Y; Deng Y; Song Y
Drug Deliv; 2018 Nov; 25(1):1200-1212. PubMed ID: 29791241
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity.
Luo X; Liu M; Hu L; Qiu Q; Liu X; Li C; Lu M; Liu Y; Zhang T; Zhou S; McClements DJ; Jia X; Deng Y; Song Y
Int J Pharm; 2018 Aug; 547(1-2):315-329. PubMed ID: 29886095
[TBL] [Abstract][Full Text] [Related]
4. Are third-generation active-targeting nanoformulations definitely the best? In vitro and in vivo comparisons of pixantrone-loaded liposomes modified with different sialic acid derivatives.
Song Y; She Z; Huang Z; Wang S; Liu X; Zhang Q; Sun J; Di D; Deng Y
Drug Deliv Transl Res; 2022 Mar; 12(3):647-661. PubMed ID: 33928513
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamics of liposomes modified with different chain length of sialic acid derivatives].
Song YZ; Huang ZJ; Luo X; Wang MJ; Zheng JH; Shi J; Deng YH
Yao Xue Xue Bao; 2016 Feb; 51(2):316-24. PubMed ID: 29856587
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.
Zhou S; Zhang T; Peng B; Luo X; Liu X; Hu L; Liu Y; Di D; Song Y; Deng Y
Int J Pharm; 2017 May; 523(1):203-216. PubMed ID: 28336455
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid-octadecylamine conjugate.
Sun J; Song Y; Lu M; Lin X; Liu Y; Zhou S; Su Y; Deng Y
Eur J Pharm Sci; 2016 Oct; 93():177-83. PubMed ID: 27539143
[TBL] [Abstract][Full Text] [Related]
8. Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy.
Ding J; Zhao D; Hu Y; Liu M; Liao X; Zhao B; Liu X; Deng Y; Song Y
Int J Pharm; 2019 Nov; 571():118706. PubMed ID: 31593811
[TBL] [Abstract][Full Text] [Related]
9. Targeting of TAMs with freeze-dried monosialotetrahexosylganglioside and sialic acid-octadecylamine co-modified liposomes remodels the tumor microenvironment and enhances anti-tumor activity.
Wei L; Zhao D; Sun W; Lin L; Sui D; Li W; Gui Y; Wang J; Deng Y; Song Y
Eur J Pharm Biopharm; 2023 Mar; 184():50-61. PubMed ID: 36682511
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages.
Tran NP; Tran P; Yoo SY; Tangchang W; Lee S; Lee JY; Son HY; Park JS
Biomater Adv; 2023 Nov; 154():213606. PubMed ID: 37678087
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment.
Hu L; Luo X; Zhou S; Zhu J; Xiao M; Li C; Zheng H; Qiu Q; Lai C; Liu X; Deng Y; Song Y
Pharm Res; 2019 May; 36(7):97. PubMed ID: 31076925
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylserine and/or Sialic Acid Modified Liposomes Increase Uptake by Tumor-associated Macrophages and Enhance the Anti-tumor Effect.
Xu Z; Li J; Yan N; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2024 Jun; 25(5):125. PubMed ID: 38834759
[TBL] [Abstract][Full Text] [Related]
13. The selection of animal models influences the assessment of anti-tumor efficacy: promising sialic acid-conjugate modified liposomes demonstrate remarkable therapeutic effects in diverse mouse strains.
Wei L; Lin L; Wang J; Guan X; Li W; Gui Y; Liao S; Wang M; Li J; Deng Y; Song Y
Drug Deliv Transl Res; 2024 Jul; 14(7):1794-1809. PubMed ID: 38165530
[TBL] [Abstract][Full Text] [Related]
14. Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments.
Sui D; Liang K; Gui Y; Du Z; Xin D; Yu G; Zhai W; Liu X; Song Y; Deng Y
Life Sci; 2022 Dec; 310():121081. PubMed ID: 36273630
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.
Tang X; Sui D; Liu M; Zhang H; Liu M; Wang S; Zhao D; Sun W; Liu M; Luo X; Lai X; Liu X; Deng Y; Song Y
Int J Pharm; 2020 Nov; 590():119929. PubMed ID: 33010395
[TBL] [Abstract][Full Text] [Related]
16. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152
[TBL] [Abstract][Full Text] [Related]
17. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.
Qiu Q; Li C; Song Y; Shi T; Luo X; Zhang H; Hu L; Yan X; Zheng H; Liu M; Liu M; Liu M; Yang S; Liu X; Chen G; Deng Y
Acta Biomater; 2019 Jul; 92():184-195. PubMed ID: 31108259
[TBL] [Abstract][Full Text] [Related]
19. Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy.
Zhu S; Li X; Luo Z; Ding M; Shi S; Zhang T
Drug Deliv Transl Res; 2024 Mar; 14(3):718-729. PubMed ID: 37679600
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
